when was first glp 1 approved Timeline of GLP-1 discovery and clinical development. (a) Key events in FDA Approves Oral Semaglutide as

In 1993, the first small-molecule ligands, L-692,429 and its superior derivative, L-163,191 (MK-0677), were developed, further accelerating research in this field (Table 1) (Smith et al., 1993

To make the current evidence and gaps explicit, we now include Table 2 summarizing representative ferroptosis-in-AD studies (human, animal, and cellular), indicating which hallmarks were examined and whether selective rescue or checkpoint linkage was established (Bao et al., 2021

Conduct necessary lab work: Baseline and ongoing lab tests are crucial to monitor your health, adjust dosages, and ensure the treatment remains safe and effective for your body

Given these considerations, the approach to patch testing differs significantly across international guidelines

Acknowledgements We gratefully acknowledge the valuable cooperation of Huiping Ma (Center of Animal Experiment, Chinese Peoples Liberation Army Joint Logistic Support Force 940th Hospital) in preparing this animal model experiment